/// Tag

Pharmaceutical communication

← Back to blog

Science or advertising? The error in pharmaceutical communication that can trigger fines
Public Relations
Science or advertising? The error in pharmaceutical communication that can trigger fines

The pharmaceutical industry faces a challenge few industries share: communicating innovation without the message being interpreted as improper advertising. In Mexico, where regulation of health-supply advertising is overseen by the Federal Commission for the Protection against Sanitary Risks (COFEPRIS), the difference between informing and promoting can have implications…

Aug 2026→
/// Next step

Is your brand ready to sound louder?

Tell us about your challenge, and we will be in touch shortly.

Let´s talk
WhatsApp Call us Messenger Telegram LinkedIn Instagram Email @ Send an SMS SMS